Market Whales and Their Recent Bets on BMY Options
Portfolio Pulse from Benzinga Insights
Market whales have shown a predominantly bearish stance on Bristol-Myers Squibb (BMY), with 70% of recent options trades being bearish. Analysis of options trading for BMY reveals a focus on a price range between $44.0 and $55.0. Significant trades include both puts and calls, with a higher total trade price for puts. BMY's stock is currently up by 0.97% at $48.75, with an anticipated earnings release in 10 days. The company, a leader in immuno-oncology, derives 70% of its sales from the U.S.
April 15, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Whales show a bearish stance on BMY, with a significant focus on options trading within the $44-$55 price range. The stock is currently up, with an earnings release anticipated soon.
The bearish sentiment among whales suggests caution, but the current stock uptick and upcoming earnings release could influence BMY's short-term price movement. The focus on a specific price range indicates a strategic approach to options trading, reflecting market expectations and potential volatility. The importance is high due to the direct impact of whale trades and earnings anticipation on investor sentiment and stock performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100